.sacrocuore.it
May 7, 2025, 03:26
Luca Nicosia: PLATO ATC4 phase II trial presented at ESTRO25
Luca Nicosia, Radiation Oncologist at the Department of Advanced Radiation Oncology at IRCCS, shared a post on X:
“PLATO ATC4 phase II trial
- Reduced dose for T1 T2 <4 cm achieved similar results to standard dose.
- Reduced treatment interruption
- optimal QoL.”
More posts featuring ESTRO.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 1, 2025, 19:24
Aug 1, 2025, 19:14
Aug 1, 2025, 18:32